: A Comparison of Neuromuscular Transmission in the Muscles During General Anesthesia

NCT04845386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2022-05-31

No results posted yet for this study

Summary

The investigators want to compare new muscle relaxation monitoring, TOF-Cuff and TOF-Scan, during general anesthesia. Standard monitoring is using thumb, however it can't be use on every patient. Alternative can be eyebrow muscle or foot muscle.

There is only few old study that compares this muscle and used mivacurium. The study aims to compare TOF-Cuff and TOF-Scan with different sensor and use mivacurium.

Conditions

  • Neuromuscular Blockade

Interventions

DEVICE

TOF Cuff on arm

The TOF Cuff will be installed on one arm in opposite of TOF Scan. After intubation dose of mivacurium continuous monitoring of neuromuscular block started until complete recovery of neuromuscular block.

DEVICE

TOF Cuff on lower leg

The TOF Cuff will be installed on one lower leg. After intubation dose of mivacurium continuous monitoring of neuromuscular block started until complete recovery of neuromuscular block.

DEVICE

TOF Scan on toe

The TOF Scan will be installed on hallux . After intubation dose of mivacurium continuous monitoring of neuromuscular block started until complete recovery of neuromuscular block.

DEVICE

TOF Scan on adductor pollicis

The TOF Scan will be installed on Thumb. After intubation dose of mivacurium continuous monitoring of neuromuscular block started until complete recovery of neuromuscular block.

DEVICE

TOF Scan on corrugator supercilii

The TOF Scan will be installed on corrugator supercilii. After intubation dose of mivacurium continuous monitoring of neuromuscular block started until complete recovery of neuromuscular block.

Sponsors & Collaborators

  • Regional Specialized Hospital in Olsztyn

    collaborator UNKNOWN
  • University of Warmia and Mazury in Olsztyn

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-25
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04845386 on ClinicalTrials.gov